APLS
Apellis Pharmaceuticals Inc
3.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | 0.0% | – | – | – | 0.0% | – | – | – | – | – | – | 14,428.3% | 0.1% | – | 23,425.8% | 2.6% | 0.7% | 8.7% | 0.5% | 6.3% | 12.9% | 17.4% | 8.8% | 20.3% | 13.6% | 12.0% | 11.8% | 17.0% | 19.2% | 20.6% | 7.9% | 5.3% | 14.9% | 15.2% | 9.9% | |
| – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | 100.0% | 99.9% | – | -23,325.8% | 97.4% | 99.3% | 91.3% | 99.5% | 93.7% | 87.1% | 82.6% | 91.2% | 79.7% | 86.4% | 88.0% | 88.2% | 83.0% | 80.8% | 79.4% | 92.1% | 94.7% | 85.1% | 84.8% | 90.1% | |
| – | – | – | – | – | – | 113,784.4% | – | – | – | 266,903.5% | – | – | – | – | – | – | 14,428.3% | 30.2% | – | 23,425.8% | 1,552.8% | 179.4% | 632.4% | 622.8% | 431.7% | 438.7% | 245.3% | 100.7% | 71.9% | 47.3% | 49.2% | 39.0% | 45.0% | 35.9% | 51.8% | 37.5% | 14.9% | 37.1% | 28.7% | 25.9% | |
| – | – | – | – | – | – | 42,107.1% | – | – | – | 55,371.7% | – | – | – | – | – | – | 5,726.2% | 17.8% | – | 7,859.9% | 810.0% | 68.8% | 355.9% | 387.2% | 355.5% | 372.3% | 227.7% | 117.3% | 131.9% | 96.8% | 75.2% | 64.1% | 62.0% | 18.0% | 77.5% | 73.5% | 31.1% | 73.6% | 46.3% | 49.3% | |
| – | – | – | – | – | – | 155,891.5% | – | – | – | 322,275.2% | – | – | – | – | – | – | 20,154.5% | 47.8% | – | 7,859.9% | 2,362.8% | 247.6% | 988.3% | 1,010.1% | 787.1% | 811.0% | 473.0% | 218.0% | 203.9% | 144.1% | 124.0% | 103.0% | 107.0% | 93.1% | 129.4% | 110.8% | 46.0% | 110.7% | 75.0% | 75.2% | |
| – | – | – | – | – | – | -155,891.5% | – | – | – | -322,275.2% | – | – | – | – | – | – | -20,054.5% | 52.0% | – | -31,185.7% | -2,265.4% | -148.3% | -897.0% | -910.6% | -693.4% | -723.9% | -390.4% | -126.8% | -124.2% | -57.7% | -36.0% | -14.7% | -24.0% | -12.3% | -50.0% | -18.6% | 48.7% | -25.6% | 9.9% | 14.9% | |
| – | – | – | – | – | – | 839.7% | – | – | – | 5,409.5% | – | – | – | – | – | – | 1,470.4% | 3.8% | – | 604.7% | 40.4% | 5.0% | 59.4% | 51.8% | 35.8% | 34.1% | 16.8% | 7.7% | 6.6% | 5.1% | 4.0% | 4.7% | 6.4% | 5.4% | 6.6% | 6.2% | 2.5% | 5.4% | 3.8% | 3.9% | |
| – | – | – | – | – | – | -158,170.2% | – | – | – | -315,881.1% | – | – | – | – | – | – | -21,006.2% | 32.0% | – | -35,183.1% | -3,461.4% | -245.0% | -957.7% | -952.6% | -865.2% | -738.9% | -395.8% | -128.3% | -126.8% | -59.5% | -38.4% | -18.8% | -28.9% | -17.0% | -55.1% | -23.4% | 47.2% | -29.3% | 7.1% | 12.2% | |
| – | – | – | – | – | – | -155,051.1% | – | – | – | 20,646.3% | – | – | – | – | – | – | 1,468.0% | 0.7% | – | 594.9% | 38.3% | 0.3% | 8.4% | 3.0% | 2.0% | -6.5% | 0.6% | 0.2% | 0.2% | 1.0% | 0.1% | 0.1% | 0.3% | 0.1% | 0.2% | 0.3% | 0.1% | 0.2% | 0.2% | 0.2% | |
| – | – | – | – | – | – | -158,170.2% | – | – | – | -315,881.1% | – | – | – | – | – | – | -21,006.2% | 31.3% | – | -35,183.1% | -3,461.4% | -245.4% | -966.1% | -955.6% | -867.2% | -732.4% | -396.4% | -128.5% | -127.0% | -60.5% | -38.5% | -18.9% | -29.2% | -17.1% | -55.3% | -23.6% | 47.0% | -29.5% | 7.0% | 12.1% | |
| – | – | – | – | – | – | -155,891.5% | – | – | – | -310,474.8% | – | – | – | – | – | – | -19,487.0% | 36.0% | – | -34,506.6% | -3,416.2% | -239.4% | -895.8% | -898.8% | -827.7% | -702.9% | -378.1% | -120.1% | -119.8% | -54.1% | -34.1% | -13.9% | -22.3% | -11.3% | -48.2% | -16.9% | 49.7% | -23.7% | 11.1% | 16.3% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.